Immunogenicity and Safety of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given as a Booster at Age 15-18 Months
Clinical trial NCT03671616 · COMPLETED
Trial details
- NCT number
- NCT03671616
- Sponsor
- Statens Serum Institut
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-15
- Primary completion
- 2018-10-03
- Enrollment
- 666
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.